PH+ ALL
Clinical trials for PH+ ALL explained in plain language.
Never miss a new study
Get alerted when new PH+ ALL trials appear
Sign up with your email to follow new studies for PH+ ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New leukemia combo aims to wipe out cancer cells faster
Disease control Recruiting nowThis study tests a new drug, olverembatinib, combined with chemotherapy against standard targeted therapy plus chemo for people newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). About 350 adults will join this global trial. The goal is …
Matched conditions: PH+ ALL
Phase: PHASE3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New combo therapy aims to tame aggressive leukemia with less toxicity
Disease control Recruiting nowThis study tests a new treatment for adults newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), a fast-growing blood cancer. It combines low-intensity chemotherapy with targeted drugs (venetoclax, blinatumomab, and olverembatinib) to impr…
Matched conditions: PH+ ALL
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 22, 2026 14:03 UTC